Improvement of glucose and lipid metabolism with pegylated interferon-α plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus-Reference-Cited by-同舟云学术

Improvement of glucose and lipid metabolism with pegylated interferon-α plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus

Published:2015-07 Issue:4 Volume:35 Page:293-297
ISSN:0256-4947
Container-title:Annals of Saudi Medicine
language:en
Short-container-title:Annals of Saudi Medicine

Author:

Qing Shao¹,Ji Dong¹²,Li Bing¹,Li Fan¹,Wang Yudong³,Niu Xioaxia¹,Ling Binfang⁴,Meng Yuhua⁴,Lau George³,Chen Guofeng¹

Affiliation:

1. Liver Cirrhosis Diagnosis and Treatment Second Center, 302 Military Hospital of China, Beijing, China

2. Liver FailureTreatment and Research Center, 302 Military Hospital of China, Beijing, China

3. Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China

4. Nursing Department, 302 Military Hospital of China, Beijing, China

Funder

Chinese Medical Association Clinical Medicine

Publisher

King Faisal Specialist Hospital and Research Centre

Subject

General Medicine

Reference14 articles.

1. Hepatitis C: prevalence, transmission, screening, and prevention[J];Metts J1;FP Essent,2014

2. Assessment of outcomes of hepatitis C treatment[J];Chavez-Tapia NC;JAMA,2014

3. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C[J];Sanyal AJ;Liver Int,2011

4. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice[J];Fransen VDPD;Ann Hepatol,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection;Life;2023-02-15

2. The art of managing hepatitis C virus in special population groups: a paradigm shift;Egyptian Liver Journal;2022-11-15

3. Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection;Biomedicines;2022-08-26

4. Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-04

5. Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study;Metabolism Open;2021-06